|
|
|
Insider
Information: |
Aselage Steve |
Relationship: |
Director |
City: |
Fremont |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
293,421 |
|
Indirect Shares
|
19,500 |
|
|
Direct
Value |
$6,739,296 |
|
|
Indirect Value
|
$118,170 |
|
|
Total
Shares |
312,921 |
|
|
Total
Value |
$6,857,466 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
4
|
5
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
4
|
2
|
|
|
|
Gain/Loss Ratio : |
-4.0
|
1.5
|
Percentage
Gain/Loss : |
-31.1%
|
62.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cti Biopharma Corporation |
CTIC |
EVP, Global Commercial... |
2005-06-30 |
24,133 |
2004-08-03 |
0 |
Premium* |
|
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Business Of... |
2012-07-02 |
59,030 |
2006-04-28 |
0 |
Premium* |
|
Travere Therapeutics, Inc |
TVTX |
Director |
2022-05-11 |
146,919 |
2021-11-05 |
19,500 |
Premium* |
|
Acer Therapeutics Inc |
ACER |
Director |
2023-11-17 |
0 |
2017-09-19 |
0 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2023-06-13 |
63,339 |
2019-03-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
169 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2011-04-29 |
4 |
A |
$11.64 |
$18,583 |
D/D |
1,597 |
31,478 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2012-04-30 |
4 |
A |
$19.35 |
$19,462 |
D/D |
1,006 |
47,685 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev. |
|
2008-05-02 |
4 |
OE |
$7.16 |
$20,764 |
D/D |
2,900 |
36,460 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP Global Commercial Ops |
|
2004-08-03 |
4 |
B |
$5.25 |
$21,000 |
D/D |
4,000 |
20,000 |
2.74 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2019-11-18 |
4 |
B |
$1.45 |
$21,750 |
D/D |
15,000 |
21,672 |
2.39 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
|
2019-02-11 |
4 |
AS |
$21.38 |
$22,770 |
D/D |
(1,065) |
258,707 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
|
2019-02-12 |
4 |
AS |
$21.50 |
$22,898 |
D/D |
(1,065) |
257,642 |
0 |
- |
|
ACER |
Acer Therapeutics Inc |
Director |
|
2017-12-14 |
4 |
B |
$12.00 |
$24,000 |
D/D |
2,000 |
13,905 |
2.39 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev |
|
2008-04-01 |
4 |
AS |
$35.75 |
$29,024 |
D/D |
(805) |
32,034 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2019-05-14 |
4 |
AS |
$17.79 |
$32,698 |
D/D |
(1,838) |
257,804 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2019-05-15 |
4 |
AS |
$17.82 |
$32,753 |
D/D |
(1,838) |
255,966 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Ops |
|
2006-11-29 |
4 |
OE |
$7.16 |
$35,800 |
D/D |
5,000 |
7,829 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev |
|
2007-10-01 |
4 |
OE |
$7.16 |
$35,800 |
D/D |
5,000 |
9,895 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev |
|
2008-01-02 |
4 |
OE |
$7.16 |
$35,800 |
D/D |
5,000 |
12,034 |
0 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2020-05-05 |
4 |
AS |
$15.88 |
$39,700 |
D/D |
(2,500) |
253,857 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2020-02-05 |
4 |
AS |
$16.62 |
$41,550 |
D/D |
(2,500) |
248,466 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2021-05-11 |
4 |
S |
$19.58 |
$42,023 |
D/D |
(2,146) |
186,794 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2020-05-14 |
4 |
AS |
$15.09 |
$46,206 |
D/D |
(3,062) |
245,732 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2020-08-05 |
4 |
AS |
$19.68 |
$49,200 |
D/D |
(2,500) |
236,232 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2020-11-05 |
4 |
AS |
$21.26 |
$53,150 |
D/D |
(2,500) |
233,732 |
0 |
% |
|
CTIC |
Cti Biopharma Corporation |
EVP, Global Commercial Ops |
|
2004-02-18 |
4 |
B |
$8.90 |
$54,000 |
D/D |
6,000 |
6,000 |
2.74 |
- |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2022-05-11 |
4 |
S |
$21.92 |
$56,457 |
D/D |
(2,575) |
146,919 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2020-05-13 |
4 |
AS |
$16.41 |
$66,674 |
D/D |
(4,063) |
248,794 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Director |
|
2020-03-05 |
4 |
S |
$15.36 |
$66,939 |
D/D |
(4,359) |
256,357 |
0 |
% |
|
TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
|
2016-11-22 |
4 |
S |
$21.30 |
$68,160 |
D/D |
(3,200) |
240,556 |
0 |
- |
|
169 Records found
|
|
Page 4 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|